Whole-body screening of atherosclerosis with magnetic resonance angiography

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 5, 2007, Pages 329-337

  Hansen, Tomas ^a   Ahlström, Håkan ^a   Johansson, Lars ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Magnetic resonance angiography; Review

Indexed keywords

ANKLE BRACHIAL INDEX; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; HUMAN; IONIZING RADIATION; MAGNETIC RESONANCE ANGIOGRAPHY; PRIORITY JOURNAL; REVIEW; SCREENING;

ATHEROSCLEROSIS; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 36349000338     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/rmr.0b013e318159aaa2     Document Type: Review

References (58)

1. Mackay JMG. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
2. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004;25:1197-1207.
3. Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med. 2002;21:213-237.
4. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque: Part I: Evolving concepts. J Am Coll Cardiol. 2005;46:937-954.
5. Corti R, Hutter R, Badimon JJ, et al. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis. 2004;17:35-44.
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
7. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104:503-516.
8. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126.
9. Fuster V, Fayad ZA, Moreno PR, et al. Atherothrombosis and high-risk plaque: Part II: Approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005;46:1209-1218.
10. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
11. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Arch Mal Coeur Vaiss. 2004;97:1019-1030.
12. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient - Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H-15H.
13. Simon A, Giral P, Levenson J. Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Association with coronary risk profile. Circulation. 1995;92:1414-1421.
14. Redberg RF. Coronary artery calcium: should we rely on this surrogate marker? Circulation. 2006;113:336-337.
15. Gray-Weale AC, Graham JC, Burnett JR, et al. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg (Torino). 1988;29:676-681.
16. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov. 2004;3:913-925.
17. Lekakis JP, Papamichael CM, Cimponeriu AT, et al. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol. 2000;85:949-952.
18. Bots ML, Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther. 2002;16:341-351.
19. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis. 2005;181:125-130.
20. Joakimsen O, Bonaa KH, Stensland-Bugge E, et al. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: the Tromso Study. Arterioscler Thromb Vasc Biol. 1999;19:3007-3013.
21. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
22. Rodriguez-Macias KA, Lind L, Naessen T. Thicker carotid intima layer and thinner media layer in subjects with cardiovascular diseases. An investigation using noninvasive high-frequency ultrasound. Atherosclerosis. 2006;189:393-400.
23. Nicholls SJ, Tuzcu EM, Crowe T, et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol. 2006;47:1967-1975.
24. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761-1791.
25. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682-696.
26. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
27. Heald CL, Fowkes FG, Murray GD, et al. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189:61-69.
28. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172:95-105.
29. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed. 2006;19:636-654.
30. Yuan C, Beach KW, Smith LH Jr, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998;98:2666-2671.
31. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333-2342.
32. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
33. Zhang H, Maki JH, Prince MR. 3D contrast-enhanced MR angiography. J Magn Reson Imaging. 2007;25:13-25.
34. Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-649.
35. Prince MR, Meaney JF. Expanding role of MR angiography in clinical practice. Eur Radiol. 2006;16:B3-B8.
36. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology. 2002;224:270-277.
37. Lin J, Chen B, Wang JH, et al. Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels. 2006;21:395-398.
38. Nael K, Ruehm SG, Michaely HJ, et al. Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol. 2007;188:529-539.
39. Rigatelli G, Roncon L, Bedendo E, et al. Concomitant peripheral vascular and coronary artery disease: a new dimension for the global endovascular specialist? Clin Cardiol. 2005;28:231-235.
40. Ruehm SG, Goehde SC, Goyen M. Whole body MR angiography screening. Int J Cardiovasc Imaging. 2004;20:587-591.
41. Goyen M, Herborn CU, Kroger K, et al. Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol. 2006;16:685-691.
42. Hansen T, Wikstrom J, Eriksson MO, et al. Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol. 2006;16:147-153.
43. Herborn CU, Goyen M, Quick HH, et al. Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol. 2004;182:1427-1434.
44. Goehde SC, Hunold P, Vogt FM, et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. AJR Am J Roentgenol. 2005;184:598-611.
45. Hansen T, Wikstrom J, Johansson LO, et al. The prevalence and quantification of atherosclerosis in an elderly population assessed by whole-body magnetic resonance angiography. Arterioscler Thromb Vasc Biol. 2007;27:649-654.
46. Barbier CE, Bjerner T, Johansson L, et al. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48:765-771.
47. Ebeling Barbier CBT, Hansen T, Lind L, et al. MRI-detected unrecognized myocardial infarction may not associated with atherosclerosis. Radiology. In press.
48. Kramer H, Schoenberg SO, Nikolaou K, et al. Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005;236:300-310.
49. Fenchel M, Requardt M, Tomaschko K, et al. Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging. 2005;21:596-603.
50. Fenchel M, Scheule AM, Stauder NI, et al. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology - initial clinical results. Radiology. 2006;238:280-291.
51. Hoogeveen RM, Bakker CJ, Viergever MA. Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging. 1998;8:1228-1235.
52. Birnbaum Y, Fishbein MC, Luo H, et al. Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease. J Am Coll Cardiol. 1997;30:1149-1164.
53. Pasterkamp G, Schoneveld AH, van Wolferen W, et al. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. Arterioscler Thromb Vasc Biol. 1997;17:3057-3063.
54. Pasterkamp G, Galis ZS, de Kleijn DP. Expansive arterial remodeling: location, location, location. Arterioscler Thromb Vasc Biol. 2004;24:650-657.
55. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251-262.
56. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg. 2001;33:91-96.
57. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006;241:861-872.
58. Hansen T. Assessment of Atherosclerosis by Whole-Body Magnetic Resonance Angiography [doctoral thesis]. Uppsala, Sweden: Uppsala University; 2007.